Long-term safety and efficacy of lumacaftor/ivacaftor in children aged ≥12 months of age with cystic fibrosis: a 96-week open-label study.
Overview & Synopsis
Open access biomedical research article published in ERJ Open Res.
Indexed from repository: PubMed Central
(
pmc.ncbi.nlm.nih.gov)
Keyboard Shortcuts:
← / → for pages • + / - for zoom • 0 to fit width
Powered by Mozilla PDF.js v3.11
Document Information
| Document Title | Long-term safety and efficacy of lumacaftor/ivacaftor in children aged ≥12 months of age with cystic fibrosis: a 96-week open-label study. |
|---|---|
| Author / Organization | Zemanick ET, McColley SA, Linnemann RW, Rayment JH, Harris WT, Ramsey B, McKone EF, Tullis E, Mall MA, Taylor-Cousar JL, Sosnay PR, Ahluwalia N, Liu L, Jennings M, Rosenfeld M |
| Subject & Discipline | ERJ Open Res |
| Categories | Medicine & Health |
| Publication Year | 2026 |
| License / Rights | Open Access / Creative Commons |
| Resource Verification | Listed PDF (Verification Pending) |
| Original Host Website |
PubMed Central
(pmc.ncbi.nlm.nih.gov)
|
| File Format | application/pdf (Portable Document Format) |
| Language | EN |
| Catalog ID | DOC-120593 |
| Original Source Link | Visit Source Page on pmc.ncbi.nlm.nih.gov » |